Alonso Juan, Barbier Luis, Alvarez Julio, Romo Laura, Martín Jesús C, Arteagoitia Iciar, Santamaría Joseba
Servicio de Cirugía Maxilofacial, Hospital de Cruces, Osakidetza.
Med Oral Patol Oral Cir Bucal. 2005 Aug-Oct;10(4):362-6.
Cervical cystic lymphangioma (CCL) is a rare and benign tumour involving congenital and cystic abnormalities derived from lymphatic vessels. The most accepted treatment continues to be surgical excision. However, when this infiltrates vital neurovascular neck structures, complete excision is difficult and if only partial, the recurrence rate is very high. The most frequently used alternative treatment is to inject sclerosants into the lesion. The use of these techniques has reported good results in children; however, there are few references thereof with regard to adults. We are reporting on a cervical cystic lymphangioma in a male aged 22, treated with an intra-lesion injection of 20 cc with 0.01 mg/cc dilution of OK-432 (picibanil) in physiological serum. Sole complications were fever and local reaction where the solution was injected. One month after treatment the lymphangioma had totally remitted and sixteen months later continues in remittance.
颈部囊性淋巴管瘤(CCL)是一种罕见的良性肿瘤,涉及源自淋巴管的先天性和囊性异常。目前最常用的治疗方法仍然是手术切除。然而,当肿瘤浸润颈部重要的神经血管结构时,完整切除困难,若仅部分切除,复发率非常高。最常用的替代治疗方法是向病变部位注射硬化剂。这些技术在儿童中应用已取得良好效果;然而,关于成人的相关报道较少。我们报告一例22岁男性颈部囊性淋巴管瘤,采用在生理盐水中将0.01mg/cc的溶链菌制剂(匹克西尼)稀释后向瘤体内注射20cc进行治疗。唯一的并发症是发热和注射部位的局部反应。治疗后1个月淋巴管瘤完全消退,16个月后仍持续缓解。